Research programme: alkaloid-conjugate analgesics - Chimeracom
Alternative Names: Chimeric hybrid molecules; Hybrid chimeraLatest Information Update: 04 Nov 2017
At a glance
- Originator Chimeracom LLC
- Class
- Mechanism of Action Neurokinin 1 receptor agonists; Opioid mu receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Pain in USA
- 31 Oct 2007 Preclinical development is ongoing
- 25 Aug 2005 Preclinical trials in Pain in USA (unspecified route)